What does CUSIP 62856X102 represent in this 13F holders report?

CUSIP 62856X102 is the security identifier for MYMD - MYMD PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held MYMD - MYMD PHARMACEUTICALS INC - COM in Q4 2022?

37 institutional investors reported MYMD - MYMD PHARMACEUTICALS INC - COM for Q4 2022. Use the holders table for investor-level position and value details.

MYMD PHARMACEUTICALS INC - COM (MYMD)

CUSIP: 62856X102

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / COM
Total 13F shares: 3,899,398
Total 13F value: $4,491,424
Share change: +56,465
Put/Call ratio: 51%
SEC-reported price per share: $1.15
Number of holders: 37
Value change: -$129,947
Number of buys: 18
Number of sells: 15

Security key

62856X102

Report period

Q4 2022

Institutions

Top holders

MYMD full security history Ownership snapshot Full 13F holder table Q/C TECHNOLOGIES, INC. SEC filings Q/C TECHNOLOGIES, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MYMD - MYMD PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

0/15

Latest evidence

30 Sep 2022

13F Highest disclosed value: $3,804,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $3.8M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Disclosed position value Top 5

VANGUARD GROUP INC $3.8M

Mirae Asset Global Investments Co... $1.67M

MORGAN STANLEY $745K

GEODE CAPITAL MANAGEMENT, LLC $712K

BlackRock Finance, Inc. $510K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$3,804,000 1,457,655 shares	—	30 Sep 2022
Mirae Asset Global Investments Co., Ltd.	13F Company 13F	— denominator unverified	$1,667,000 638,580 shares	—	30 Sep 2022
MORGAN STANLEY	13F Company 13F	— denominator unverified	$745,000 285,458 shares	—	30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$712,000 273,050 shares	—	30 Sep 2022
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$510,000 195,461 shares	—	30 Sep 2022
Shay Capital LLC	13F Company 13F	— denominator unverified	$365,000 139,986 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,899,398

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %